newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

SEATTLE, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet